Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sufentanil combined with promethazine for PCIA after thoracic surgery
ChiCTR2100044486Phase 4Recruiting
- Sponsor
- Yongchuan Hospital Affiliated to Chongqing Medical University
- Start
- Mar 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of sufentanil and promethazine in postoperative pain and postoperative nausea and vomiting (PONV) (2 arms), sponsored by Yongchuan Hospital Affiliated to Chongqing Medical University. Primary endpoints: Visual analogue scale (VAS) for pain, Blood pressure and 5 more. Started Mar 2021; status: recruiting.
02
Drugs
sufentanilpromethazine
03
Conditions
postoperative painpostoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on ChiCTR2100044486.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100044486.